HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fifis, T. Articles by Plebanski, M. Search for Related Content PubMed PubMed Citation Articles by Fifis, T. Articles by Plebanski, M.

Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors¹

Austin Research Institute, Austin Hospital, Heidelberg, Victoria, Australia

Infection can protect against subsequent disease by induction of both humoral and cellular immunity, but inert protein-based vaccines are not as effective. In this study, we present a new vaccine design, with Ag covalently conjugated to solid core nano-beads of narrowly defined size (0.04–0.05 µm) that localize to dendritic cells (DEC205⁺ CD40⁺, CD86⁺) in draining lymph nodes, inducing high levels of IFN- production (CD8 T cells: precursor frequencies 1/5000 to 1/1000) and high Ab titers in mice. Conjugation of Ag to these nano-beads induced responses that were significantly higher (2- to 10-fold) than those elicited by other bead sizes, and higher than a range of currently used adjuvants (alum, QuilA, monophosphoryl lipid A). Responses were comparable to CFA/IFA immunization for Abs and ex vivo peptide-pulsed dendritic cell immunization for CD8 T cells. A single dose of Ag-conjugated beads protected mice from tumors in two different model challenges and caused rapid clearance of established tumors in mice. Thus, a range of Ags conjugated to nano-beads was effective as immunogens in both therapeutic and prophylactic scenarios.

This article has been cited by other articles:

				K. Broos, M. E. Janssens, I. De Goeyse, P. Vanlandschoot, G. Leroux-Roels, D. Geysen, and Y. Guisez Comparison of Serum Humoral Responses Induced by Oral Immunization with the Hepatitis B Virus Core Antigen and the Cholera Toxin B Subunit Clin. Vaccine Immunol., May 1, 2008; 15(5): 852 - 858. [Abstract] [Full Text] [PDF]